The difference between a BLA and NDA

Although there is no regulatory mechanism in the U.S. to approve a generic version of a product that is marketed under a BLA, it is possible that a generic version of a biotech product that has been approved under an NDA could be approved.

This confusing situation results because some biotech products are approved under NDAs while others are approved under BLAs.